| Reduced coronary flow reserve in isolated coronary artery ectasias | Ömer AKYÜREK,Berkten BERKALP,Tamer SAYIN,İrem DİNÇER,Celal KERVANCIOĞLU,Derviş ORAL | 161–167 |
| Angiotensin I converting enzyme gene polymorphism in type 2 diabetes mellitus patients with myocardial infarction | Bekir ÇAKIR,Rıdvan Seçkin ÖZEN,Serdar GÜLER,Özlem DURMUŞ,Funda Elif ORKUNOĞLU,Zeynel BEYHAN,Necat İMİRZALIOĞLU | 168–174 |
| Effects of glycoprotein IIb/IIIa inhibition with tirofiban on in-hospital major cardiac events in patients with unstable angina pectoris and non Q wave myocardial infarction | Ertan ÖKMEN,Mahmut ÇAKMAK,Seden ÇELİK,Hüseyin TUNAR,Hale YILMAZ,İzzet ERDİNLER,Recep ÖZTÜRK,Neşe ÇAM | 175–180 |
| Risk factors for the development of atrial fibrilation in patients with mitral stenosis | İrem DİNÇER,Tolga KOÇUM,Ömer AKYÜREK,Çetin EROL,Derviş ORAL | 181–184 |
| Effect of losartan on circulating tumor necrosis factor-alpha levels and left ventricular systolic performance in patients with heart failure | Adalet GÜRLEK,Mustafa KILIÇKAP,Rabih DANDACHİ,İrem DİNÇER,Hüseyin TUTKAK,Derviş ORAL | 185–188 |
| Comparison of cerivastatin and atorvastatin in hypercholesterolemia | Ilgın KARACA,Mehmet AKBULUT,Erdoğan İLKAY,Murat PEKDEMİR,Zafer ÖZDAĞ,Nadi ARSLAN | 189–193 |
| The significance of inversion U wave during exercise ECG | Bülent B. ALTUNKESER,Kurtuluş ÖZDEMİR,Ahmet TEMİZHAN,Hasan GÖK | 194–197 |
| Measurement of right and left ventricular myocardial performance indexes, and transmitral flow propagation velocity in healthy children | Mete ALPASLAN,Ersel ONRAT,Mustafa TUNGA,Tolga Altuğ ŞEN,İsmet DOĞAN | 198–202 |
| Five year follow-up results of patients with myocarditis | Hilkay Tuba KARAPINAR,Mithat KUŞKAYA,Timur MEŞE,Hasan AĞIN,Şükrü CANGAR | 203–206 |
| Clinical approach to adult type atrial septal defects | Melih Hulusi US,Yılmaz CİNGÖZBAY,Turan EGE,Mutasım SÜNGÜN,Enver DURAN,Ömer Yüksel ÖZTÜRK | 207–211 |
| Giant subclavion artery aneurysm | Erdal EGE,MUSTAFA PAÇ,Abdussamet HAZAR,Mustafa EMMİLER,Nurzat ELMALI |